Avadel Pharmaceuticals

NASDAQ

AVDL

$18.82 0.52 2.76%

Today share price

Ireland

Sector: Healthcare Industry: Pharmaceuticals

Get access
to the rating of Finrange stocks

With this tariff you will be able to use the service without restrictions, all information will be available

Get 7 days free

1.79B

1.76B

1.17

95.02M

33.29 %

Indicator	Company	Industry
P/E (LTM) Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months. More	-11.16	8.74
P/BV (LTM) Shows the ratio of the market price of the share to the current book value. More	20.38	22.34
EV/EBITDA (LTM) Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months. More	-12.92	4.38
Net Debt/EBITDA (LTM) A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt. More	0.22	0.50
ROE (LTM) Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months. More	-182.67	9.54

4.95$ 10.80$

Min Max

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. The company's lead product candidate is FT218, a formulation of sodium oxybate which is in a Phase 3 clinical trial for the treatment excessive daytime sleepiness (EDS) and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals PLC in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.

Address:

10 Earlsfort Terrace, Dublin, Ireland, 2

Company name:

Avadel Pharmaceuticals

Issuer ticker: AVDL

ISIN: US05337M1045

Country: Ireland

Exchange: NASDAQ

Currency: $

IPO date: 1996-06-07

Sector: Healthcare

Industry: Pharmaceuticals

Site:

https://www.avadel.com

On which stock exchange are Avadel Pharmaceuticals (AVDL) stocks traded?

Avadel Pharmaceuticals (AVDL) stocks are traded on NASDAQ.

What is the ticker of Avadel Pharmaceuticals stocks (AVDL)?

The stock ticker of Avadel Pharmaceuticals’s stocks or in other words, the code is AVDL. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Avadel Pharmaceuticals (AVDL) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Avadel Pharmaceuticals (AVDL) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are Avadel Pharmaceuticals (AVDL) stocks traded?

Avadel Pharmaceuticals (AVDL) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Avadel Pharmaceuticals (AVDL) stocks today?

The current price of Avadel Pharmaceuticals stocks on 05.05.2024 is 18.82 dollars. per share.

What is the dynamics of Avadel Pharmaceuticals (AVDL) stocks from the beginning of the year?

Avadel Pharmaceuticals (AVDL) quotes have increased by 31.79% from the beginning of the year up to 18.82 dollars. per 1 stocks.

How much did Avadel Pharmaceuticals (AVDL) stocks increase in мае 2024?

This month Avadel Pharmaceuticals (AVDL) quotes have increased by 2.79% to 18.82 dollars. per share.

How much are Avadel Pharmaceuticals (AVDL) stocks worth?

Today, on October, 05.05.2024 Avadel Pharmaceuticals’s (AVDL) stocks cost 18.82 dollars..

What is the market capitalization of Avadel Pharmaceuticals (AVDL)?

Capitalization is the market value of Avadel Pharmaceuticals (AVDL) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 05.05.2024, the market capitalization of Avadel Pharmaceuticals (AVDL) is estimated at about 1788257580 dollars.

Avadel Pharmaceuticals

Rating Finrange

Upcoming events Avadel Pharmaceuticals

Stock chart Avadel Pharmaceuticals

Stock analysis Avadel Pharmaceuticals

Price change Avadel Pharmaceuticals per year

Summary analysis Avadel Pharmaceuticals

Shareholder structure Avadel Pharmaceuticals

Revenue and net income Avadel Pharmaceuticals

Stock news Avadel Pharmaceuticals